Shane H.D. Morris

Shane H.D. Morris is a declared insider of Pharmala Biotech Holdings Inc., with filings sourced from SEDI. The record holds 9 filings, for trades running from 22 March 2021 to 9 December 2024.

The open-market side counts 1 purchase for €6,904 alongside 5 sales for €138k. On balance, insiders were net sellers of €131k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises. So far in 2024, the count stands at 1 purchase and no sales.

The latest filing, published on 10 December 2024, reports an option exercise in Pharmala Biotech Holdings Inc. The last purchase on record was published on 12 August 2024, which is 803 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEDI. Past trades are no guide to future returns.